Sofia Wareham-Mathiassen

Dr. Sofia Wareham-Mathiassen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
SWSofia Wareham-Mathiassen
Sofia Wareham-Mathiassen
PJPawan Jolly
Pawan Jolly
Nandhinee Radha ShanmugamNandhinee Radha Shanmugam
Nandhinee Radha Shanmugam
BJBadrinath Jagannath
Badrinath Jagannath
PPPranav Prabhala
Pranav Prabhala
DIDonald E Ingber
Donald E Ingber
Biofouling and foreign body responses have deleterious effects on the functionality and longevity of implantable biosensors, seriously impeding their implementation for long-term monitoring. Here, we describe a nanocomposite coating composed of a cross-linked lattice of bovine serum albumin and pentaamine-functionalized reduced graphene that is covalently coupled to antibody ligands for analyte detection as well as antibiotic drugs (gentamicin or ceftriaxone), which actively combats biofouling while retaining high electroconductivity and excellent electrochemical immunosensor behavior. Sensors overlaid with this coating inhibit the proliferation of Pseudomonas aeruginosa bacteria and adhesion of primary human fibroblasts while not having any significant effects on fibroblast viability or on the immune function of primary human monocytes. Under these conditions, the sensor maintains its electrochemical stability for at least 3 weeks after exposure to soluble proteins that interfere with the activity of uncoated sensors. Proof-of-concept for the coating’s applicability is demonstrated by integrating the antimicrobial coating within an immunosensor and demonstrating the detection of cytokines in both culture medium and complex human plasma. This new coating technology holds the potential to substantially increase the lifespan of implanted biosensors and widen their application areas, potentially enabling continuous monitoring of analytes in complex biofluids for weeks in vivo.

11 November 2022 in Laboratory Animals
Verified
Journal Article
Closed access
SWSofia Wareham-Mathiassen
Sofia Wareham-Mathiassen
VGVera Pinto Glenting
Vera Pinto Glenting
LBLene Bay
Lene Bay
MAMarie Allesen-Holm
Marie Allesen-Holm
HBHenrik Bengtsson
Henrik Bengtsson
TBThomas Bjarnsholt
Thomas Bjarnsholt
Pig skin is commonly used in the medical industry as an injection model due to its compelling physiological affinity to human skin. However, the pig neck skin microflora remains largely uncharacterized, which may have undesirable implications for the translatability of results to humans. This study aimed to characterize pig neck skin microbiome with direct comparison with human skin microflora at emblematic injection sites to appraise its suitability as an injection model. Ten minipigs were sampled with tape strips and swabs and analysed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry and 16S/ITS high throughput sequencing and confocal laser scanning microscopy. Results were directly compared with previous investigations of human injection sites. Pig skin was dominated by phyla 94.8% Firmicutes, 3% Proteobacteria, and 2.2% Actinobacteria. Staphylococcus spp. prevailed (44.4%) at the genus level with S. capitis and S. chromogenes present in all samples. Pig skin revealed populations in the 104 colony-forming units (CFU)/cm2 range with 3% identified as Gram-negative and increased alpha diversity (compared with 102 CFU/cm2 and 10% in humans). While notable taxonomical differences on species levels were seen, pig skin encompassed 97.1% of genera found in human samples. The increased population and variation found support the pig neck as an imperfect but fidelitous subcutaneous injection model that can adequately challenge devices from a microbial standpoint.

17 May 2022 in APMIS
Verified
Journal Article
Open access
SWSofia Wareham-Mathiassen
Sofia Wareham-Mathiassen
LBLene Bay
Lene Bay
VGVera Pinto Glenting
Vera Pinto Glenting
NFNaireen Fatima
Naireen Fatima
HBHenrik Bengtsson
Henrik Bengtsson
TBThomas Bjarnsholt
Thomas Bjarnsholt
Needle reuse is a common practice and primary cause of customer compliance issues such as pain, bruising, clogging, injection site reactions (ISR), and associated lipodystrophy. This study aimed to characterize skin microflora at injection sites and establish microbial contamination of used pen injectors and needles. The second objective was to evaluate the risk of infections during typical and repeated subcutaneous injections. 50 participants with diabetes and 50 controls (n = 100) were sampled through tape strips and skin swabs on the abdomen and thigh for skin microflora. Used pen injectors and needles were collected after in‐home use and from the hospital after drug administration by health care professionals (HCPs). Samples were analyzed by conventional culture, matrix‐assisted laser desorption/ionization‐time of flight (MALDI‐TOF), mass spectrometry (MS), confocal laser scanning microscopy (CLSM), and 16S/ITS high throughput sequencing (HTS). A mathematical model simulated the risk of needle contamination during injections. Injection site populations were in 102 cells/cm2 order, with increased viable bacteria and anaerobic bacteria on the skin in persons with diabetes (p = 0.05). Interpersonal variation dominated other factors such as sex or location. A higher prevalence of Staphylococcus aureus on abdominal skin was found in persons with diabetes than control skin (p ≤ 0.05). Most needles and cartridges (95% and 86%) contained no biological signal. The location of the device collection (hospital vs home‐use) and use regimen did not affect contamination. CLSM revealed scarcely populated skin microflora scattered in aggregates, diplo, or single cells. Our mathematical model demonstrated that penetrating bacteria colonies during subcutaneous injection is unlikely. These findings clarify the lack of documented skin infections from subcutaneous insulin injections in research. Furthermore, these results can motivate the innovation and development of durable, reusable injection systems with pharmacoeconomic value and a simplified and enhanced user experience for patients.

24 February 2025 in Materials Science and Engineering: C
Verified
Journal Article
Open access
SWSofia Wareham-Mathiassen
Sofia Wareham-Mathiassen
MNMohammed Nateqi
Mohammed Nateqi
SBSai Achyuth Badrinarayanan
Sai Achyuth Badrinarayanan
VGVera Pinto Glenting
Vera Pinto Glenting
MDMette Bjergaard Dragheim
Mette Bjergaard Dragheim
TBThomas Bjarnsholt
Thomas Bjarnsholt
Biofilm infections represent the greatest risk associated with medical devices and implants, constituting 65 %-70 % of all device associated infections. Efforts to develop antimicrobial technologies for biomedical applications aim to reduce infection rates, antibiotic use, and the induction of antimicrobial resistance. However, standard laboratory test conditions often overestimate efficacy, highlighting the need for experimental designs that simulate real-world settings. To this end, we evaluated four commercially available antimicrobial materials containing silver (AG1, AG2, AG3) or zinc (ZN1) to assess their ability to mitigate microbial proliferation in for longer duration or multi-use medical devices. The materials' homogeneity and surface topography were characterized through Scanning Electron Microscopy (SEM) coupled with Energy Dispersive Spectroscopy (EDS) and Atomic Force Microscopy (AFM). Antimicrobial efficacy was tested using a modified ISO 22196 protocol under clinically relevant conditions and a dry contact test developed to mimic in-use conditions for many extracorporeal medical devices. Results revealed homogeneous elemental distributions in AG1, AG2, and ZN1, and heterogeneous clusters for AG3. Surface roughness was highest for AG2 (170.1 nm), followed by TPE control (155.3 nm), ZN1 (83.51 nm) and silicone control (66.74 nm). All test materials demonstrated antimicrobial efficacies against S. aureus and E. coli, but not against C. albicans. In the dry contact assay, only AG2 proved effective against E. coli, and P. aeruginosa, underlining the role of humidity in antimicrobial action. Results were further corroborated by measurement of ion release by the materials at various temperatures, revealing greater release at higher temperatures. These outcomes emphasize the importance of testing antimicrobial materials under in use conditions to minimize discrepancies between laboratory results and clinical outcomes. Our findings provide a valuable framework for testing and integrating these materials into next-generation multi-use medical devices.

23 January 2026 in Materials Science and Engineering: C
Verified
Journal Article
Open access
SWSofia Wareham-Mathiassen
Sofia Wareham-Mathiassen
MNMohammed Nateqi
Mohammed Nateqi
SBSai Achyuth Badrinarayanan
Sai Achyuth Badrinarayanan
VGVera Pinto Glenting
Vera Pinto Glenting
MDMette Bjergaard Dragheim
Mette Bjergaard Dragheim
TBThomas Bjarnsholt
Thomas Bjarnsholt